Omzo vs Gala: Compare Compounded GLP-1 Plans and Pricing
Quick verdict: Omzo emphasizes clinician-guided, personalized compounded semaglutide starting at $179, while Gala emphasizes a flat direct-pay plan with included provider visit, free 2-day shipping, and a $220 promotion.
Explore Omzo clinician-guided plans
When evaluating Omzo vs Gala, the core difference is program structure. Both platforms offer compounded semaglutide and tirzepatide via telehealth, but Omzo centers on clinician-guided, personalized compounded medication options with pricing that starts at $179, while Gala advertises a flat, all-inclusive direct-pay plan and a $220 promotion with free two-day shipping.
Side-by-side: program model and clinician involvement
Omzo connects you with licensed U.S. providers who review plans and may prescribe either compounded medications or prescriptions for branded drugs to be filled elsewhere. Omzo states providers determine eligibility and make final prescribing decisions. Gala presents a direct-pay telehealth model that includes a provider visit and the prescription as part of the offering, with provider check-ins and dose monitoring included.
See Gala flat-price plan and provider visit
Pricing, promotions, and transparency
Omzo lists semaglutide starting at $179 and tirzepatide starting at $279 and notes medication costs are included in the fees collected by Omzo. Gala advertises a flat all-inclusive price and a $220 off promotion, but the base dollar price was not visible in the captured page text. Gala emphasizes same price at every dose and no hidden fees.
Medication format and regulatory notes
Both providers offer compounded semaglutide and tirzepatide. Both captured sources explicitly state that compounded medications, when offered, are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Omzo additionally describes that providers may instead write prescriptions for FDA-approved branded medications which the patient would fill separately; Omzo does not sell or ship branded drugs.
Delivery, enrollment features, and commitments
Gala highlights free two-day shipping, no monthly membership, and a cancel anytime policy. Omzo emphasizes fast, discreet delivery and notes FSA and HSA eligibility. Both platforms caution that eligibility, state availability, and provider decisions affect access and that individual results are not guaranteed.
Five key differences to weigh
| Criterion | Omzo | Gala |
|---|---|---|
| Program model | Clinician-guided plans reviewed by licensed U.S. providers | Direct-pay telehealth with included provider visit |
| Starting price shown | Semaglutide starting at $179 | Base price not visible; advertises $220 promotion |
| Medication type | Compounded semaglutide and tirzepatide; branded prescriptions may be written | Compounded semaglutide and tirzepatide; provider visit and prescription included |
| Shipping and fulfillment | Fast, discreet delivery; medication costs included in fees | Free 2-day shipping; home delivery emphasized |
| Regulatory note | Compounded medications are not FDA-approved | Compounded medications are not FDA-approved |
Across both sources the captured marketing includes patient testimonials and claims of weight progress, but both note that individual results vary and that providers determine medical appropriateness. Omzo explicitly states it is not a medical practice and that the online assessment does not create a doctor patient relationship; clinical services are provided through third party networks of licensed clinicians.
Compare Omzo plan details and eligibility
How provider support and costs compare
Omzo emphasizes clinician-guided planning and lists itemized starting prices for semaglutide and tirzepatide while noting that medication may be compounded and therefore not FDA-approved. Gala emphasizes an all-inclusive flat price with provider visits and ongoing check ins included and promotes no membership and cancel anytime flexibility.
Review Omzo medication options and pricing
Bottom line and recommendation
Omzo vs Gala comes down to preference for clinician-guided personalized plans and visible starting prices versus a flat direct-pay package with included provider visits and fast shipping. Both disclose that compounded medications are not FDA-approved and that provider review determines eligibility.
Choose Omzo if you want clinician-guided, personalized plans with semaglutide starting at $179 and options for branded prescriptions to fill separately, remembering compounded options are not FDA-approved. Choose Gala if you prefer a direct-pay, all-inclusive experience that advertises provider visits included, free two-day shipping, a flat price claim, and a $220 promotion.